In this MassDevice.com podcast, we speak with Glooko CEO Rick Altinger about the company's mobile diabetes management application for smartphones and how it has the potential to change the spectrum of care for one of the world's most common chronic diseases.
Renal denervation has won a lot of praise as a potential solution for patients with resistant hypertension, but the excessive celebration of early clinical trial results may be setting everyone up for a major letdown and a harsh backlash. This week cardiologists at the Transcatheter Cardiovascular Therapeutics conference, including those involved with Medtronic's and Boston Scientific's clinical trials, warned of the dangers of exaggeration.
Uroplasty says expanded insurance reimbursement will help more than 140 million patients receive percutaneous tibial nerve stimulation to treat overactive bladder using its Urgent PC device.
Uroplasty (NSDQ:UPI) said it expects over 140 million people to receive percutaneous tibial nerve stimulation to treat overactive bladder using its Urgent PC device, thanks in part to coverage expansion from major insurers.
The Emergo Group Blog provides short updates on quality and regulatory topics that may be of interest to QA/RA professionals in the medical device and IVD industry. No fluff, just straight to the point. We hope you'll enjoy the content.
New laws set to take effect in Argentina will require medical device manufacturers and importers to provide Installation, Maintenance and Service Manuals for their products only in Spanish to regulatory authority ANMAT, according to Emergo Group's Buenos Aires office.
A pair of economists face off over the medtech tax, with one calling the levy a new incentive for a complacent industry and the other warning that the tax makes for a hostile environment for medtech innovation.
MASSDEVICE ON CALL — A pair of economists have taken to the internet to pen contrary opinions on the medical device tax, with 1 arguing that the tax may be good for an industry that needs a jolt and the other warning that it could drive innovation away from the U.S.
Kelly School of Business professor emeritus Larry Davidson this week published on his blog an in-depth post decrying the tax and tearing apart arguments made by a fellow follower of the so-called "dismal science" of economics.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.